Bindu Reddy (@bindureddy)

OpenAI와 Anthropic의 연간 반복매출(ARR) 경쟁을 다룬 트윗으로, OpenAI는 약 250억 달러, Anthropic은 약 200억 달러로 추정되며 Anthropic은 손실이 더 적어 이 점에서 우위에 있다는 주장과 OpenAI의 올해 예상 손실 범위(140~200억 달러)를 제시하고 있습니다.

https://x.com/bindureddy/status/2029416617265004595

#aiindustry #openai #anthropic #financials

Air Lease Corporation: Fleet, Financials & Deal

https://misryoum.com/us/markets/air-lease-corporation-fleet-financials-deal/

Executive Summary In December 2025, shareholders approved a merger agreement under which Air Lease will be acquired for $65 per share in cash by Sumisho Air Lease, a holding company backed by Sumitomo Corporation, SMBC Aviation Capital, and investment...

#Air #Lease #Corporation #Fleet #Financials #Deal #US_News_Hub #misryoum_com

Photocure Q4 2025 Results

Photocure reported Q4 Hexvix/Cysview revenues of NOK 135.1 million (Q4 2024: NOK 128.6 million). Commercial EBITDA reached NOK 8.4 million, rising from NOK 3.9 million. For 2026, the company projects product revenue growth of 7% to 11% on a constant currency basis and continued operating leverage in its core business.

#biotech #medtech #financials #stockmarket

BICO Group Year-End Report 2025

Life Science Solutions posted 9% negative organic growth in Q4, citing lower US academic demand. Net result from continuing operations totaled SEK -59.2 million (250.5), with diluted EPS of SEK -0.84 (3.56).

#BICO #lifescience #biotech #financials

Remedy: ricavi Q4 in crescita grazie ad Alan Wake 2 e Control. Nonostante il successo, l'azienda registra una perdita operativa annuale di 14,9M€, attribuita al progetto FBC: Firebreak.

#Remedy #RemedyEntertainment #Financials #Notizievideogiochi #gamingnews #Videogiochi

👉 https://www.absolutegamer.it/remedy-ricavi-crescita-59m-2025-nonostante-perdite/

MedCap Reports Q4 Results

The company delivered organic growth and acquisition-driven expansion in the fourth quarter. Adjusted EBITA rose by 68% to SEK 112.9 million (67.4), adjusted for items affecting comparability. This growth reflects positive development in the underlying business operations.

#MedCap #lifescience #financials #stockmarket

BioGaia Preliminary Q4 Results

The company estimates operating profit at SEK 121 million (103), a 17% increase, with an operating margin of 27% (28%). Sales in Q4 2025 were positively impacted by quarterly order variations of approximately SEK 35 million.

#BioGaia #financials #lifescience #stockmarket